Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure management, in the Journal of Cardiac Failure LISLE
/PRNewswire/ Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF),.
/PRNewswire/ Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF),.